| abstract |
The present invention relates to a capsule composite formulation for the prevention or treatment of erectile dysfunction and benign prostatic hyperplasia, including tadalafil and tamsulosin, and a method of manufacturing the same. The capsule composite formulation according to the present invention can completely separate the two pharmacologically active ingredients, so that the reactivity between the active ingredients is minimized, so that the product stability according to the time change is excellent, and the therapeutic effect can be maximized. |